# BridgeBio Pharma, Inc. Common Stock (BBIO) BridgeBio Pharma's stock surges to a 52-week and all-time high following positive Phase [--] results for BBP-418, driving significant market cap growth. ### About BridgeBio Pharma, Inc. Common Stock BridgeBio Pharma, Inc. Common Stock (BBIO) is a publicly traded stock in the healthcare sector focused on developing innovative medicines. BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - BridgeBio Pharma, Inc. Common Stock (BBIO) social dominance hit [------] which is 145% higher than it's daily average. - BridgeBio Pharma, Inc. Common Stock (BBIO) trading volume is up 12.89% from the previous week. - BridgeBio Pharma, Inc. Common Stock (BBIO) market cap is up 10.58% from the previous week. - BridgeBio Pharma, Inc. Common Stock (BBIO) social dominance is up 338.71% from the previous [--] months. - BridgeBio Pharma, Inc. Common Stock (BBIO) Galaxy Score™ is up 20% from the previous week. - BridgeBio Pharma, Inc. Common Stock (BBIO) creators is up 144.3% from the previous month. - BridgeBio Pharma, Inc. Common Stock (BBIO) engagements is up 209.03% from the previous week. - BridgeBio Pharma, Inc. Common Stock (BBIO) mentions is up 128.84% from the previous month. - BridgeBio Pharma, Inc. Common Stock (BBIO) posts created is up 873.68% from the previous week. - BridgeBio Pharma, Inc. Common Stock Price hit a 52-Week high of $88 for the hour - BridgeBio Pharma, Inc. Common Stock Price hit an all time of $88 for the hour ### Price: $75.30  [Price 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/close.tsv) The stock price has surged to a 52-week and all-time high, driven by highly positive Phase [--] results for BBP-418 and strong market performance, despite some concerns about European patent issues and company debt. 24-Hour: -1.06% 7-Day: 8.06% 30-Day: -1.32% 1-Year High: $79.90 on 2026-01-22 1-Year Low: $30.10 on 2025-04-08 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/alt_rank.tsv) BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #253 based on combined combined social and market metrics Daily Average: [---] [--] Week: [---] [----] [--] Month: [---] [----] [--] Months: [---] [---] [--] Year: [---] +64 1-Year High: [-----] on 2026-01-26 1-Year Low: [--] on 2025-05-17 ### Galaxy Score: [--]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/galaxy_score.tsv) Current Value: [--] Daily Average: [--] [--] Week: [--] +8 [--] Month: [--] [---] [--] Months: [--] +10 [--] Year: [--] no change 1-Year High: [--] on 2025-12-08 1-Year Low: [--] on 2025-12-25 ### Engagements: [------] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/interactions.tsv) Current Value: [------] Daily Average: [------] [--] Week: [-------] +209% [--] Month: [---------] +86% [--] Months: [---------] -9.40% [--] Year: [----------] +8.30% 1-Year High: [-------] on 2025-02-20 1-Year Low: [-----] on 2025-12-07 Engagements by network (24h): YouTube: [--] Reddit: [--] News: [--] TikTok: [--] X: [------] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/posts_active.tsv) Current Value: [---] Daily Average: [---] [--] Week: [---] +114% [--] Month: [-----] +129% [--] Months: [-----] +0.68% [--] Year: [-----] +46% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-12-07 Mentions by network (24h): YouTube: [--] Reddit: [--] News: [--] TikTok: [--] X: [---] ### Creators: [---] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/contributors_active.tsv) [---] unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last [--] hours which is down 9.90% from [---] in the previous [--] hours Daily Average: [--] [--] Week: [---] +105% [--] Month: [---] +144% [--] Months: [-----] -12% [--] Year: [-----] +91% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-10-12 The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@semodough](/creator/twitter/semodough) | [--] | [------] | [--] | [-----] | | [@Andre_AGTC](/creator/twitter/Andre_AGTC) | [--] | [-----] | [--] | [-----] | | [@tallnfat](/creator/twitter/tallnfat) | [--] | [------] | [--] | [---] | | [@thenewceo_](/creator/twitter/thenewceo_) | [--] | [---] | [--] | [---] | | [@Pharmdca](/creator/twitter/Pharmdca) | [--] | [-------] | [--] | [---] | | [@Biotech2k1](/creator/twitter/Biotech2k1) | [--] | [------] | [--] | [---] | | [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | [--] | [-----] | [--] | [---] | | [@biomednexus](/creator/twitter/biomednexus) | [--] | [--] | [--] | [---] | | [@DwightS2025](/creator/twitter/DwightS2025) | [--] | [---] | [--] | [---] | | [@GeneInvesting](/creator/twitter/GeneInvesting) | [--] | [------] | [--] | [---] | [View More](/list/creators/$bbio/100) ### Sentiment: 83%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/sentiment.tsv) Current Value: 83% Daily Average: 77% [--] Week: 90% +5% [--] Month: 79% +20% [--] Months: 79% +2% [--] Year: 79% +14% 1-Year High: 96% on 2025-10-06 1-Year Low: 40% on 2025-05-28 Most Supportive Themes: - Positive Phase [--] Results for BBP-418: (50%) BridgeBio Pharma's drug for a muscle disorder, BBP-418, met its goals in a late-stage trial, leading to positive sentiment and stock price surges. - Strong Market Performance and Increased Market Cap: (30%) The stock's price action is also attributed to the overall strong market performance and a significant increase in market capitalization. Most Critical Themes: - FDA Hold on Intellia Therapeutics: (10%) While not directly about BBIO, news of an FDA hold on a competitor like Intellia Therapeutics can impact overall biotech sentiment and investor focus. - Debt and Cash Burn: (10%) Some posts mention the company's debt and cash burn, which could be a point of concern for investors despite positive trial results. ### Social Dominance: 0.027%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/social_dominance.tsv) Current Value: 0.027% Daily Average: 0.022% [--] Week: 0.027% +0.019% [--] Month: 0.054% +0.012% [--] Months: 0.054% +0.024% [--] Year: 0.054% +0.0089% 1-Year High: 0.068% on 2025-06-28 1-Year Low: 0.0058% on 2025-10-12 ### Market Dominance: 0.016%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/market_dominance.tsv) Current Value: 0.016% Daily Average: 0% 1-Year High: 0.018% on 2026-01-02 1-Year Low: 0.00849% on 2025-05-28 ### Market Cap: $14,419,930,847  [Market Cap 24-Hour Time-Series Raw Data](/topic/$bbio/time-series/market_cap.tsv) Current Value: $14,419,930,847 Daily Average: $9,874,616,698 [--] Week: $14,419,930,847 +11% [--] Month: $14,419,930,847 -1.30% [--] Months: $14,419,930,847 +54% [--] Year: $14,419,930,847 +117% 1-Year High: $15,312,912,611 on 2026-01-22 1-Year Low: $5,732,285,188 on 2025-04-08 ### Top BridgeBio Pharma, Inc. Common Stock Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "@BitcoinNewsCom Netherlands taxing unrealized gains is peak financial illiteracy. While you calculate paper losses $BBIO is printing 1.74-2.1 cm/year AHV gains and $SRPT durability is proven at [--] years. Move fast or stay poor" [X Link](https://x.com/thenewceo_/status/2022795342643892416) [@thenewceo_](/creator/x/thenewceo_) 2026-02-14T22:09Z [---] followers, [---] engagements "$BBIO LR Model first year [----] all [--] drugs launched [---] Billion in revenue &EPS over [--] bucks $BBIO Bernstein updating $BBIO model PT $100 to reflect positive infigratinib data. there is much more of skeletal dysplasia story still to play out and the clean safety in particular gives us greater confidence in BBIO becoming the category leader. In terms of whats next $BBIO Bernstein updating $BBIO model PT $100 to reflect positive infigratinib data. there is much more of skeletal dysplasia story still to play out and the clean safety in particular gives us greater confidence in BBIO becoming the" [X Link](https://x.com/semodough/status/2022794050596655566) [@semodough](/creator/x/semodough) 2026-02-14T22:04Z 42.5K followers, [----] engagements "Buy Verified Bitget Accounts $VERO $ACCL $IBRX $LCFY $TNMG $BIYA $GWAV $ONDS $NVO $BBIO $T $MU $NVDA $QXO $UMC $INTC $SIDU $RZLV $NOK $BMNR $KRE $GDX $ITB $SLX $TAN $IYR $ROBO $INDA $IYZ $KWEB $BLOK $IDRV $FDN $SOXX $CLOU $BITO $ARKK https://seovcc.com/product/buy-verified-bitget-accounts/ https://seovcc.com/product/buy-verified-bitget-accounts/" [X Link](https://x.com/PandyAlina45893/status/2022680546397294941) [@PandyAlina45893](/creator/x/PandyAlina45893) 2026-02-14T14:33Z [--] followers, [---] engagements "@atticusanalysis @PersimmonTI Yeah $NTLA was actually performing way better than $BBIO before the obese [--] year old with [--] ulcer came" [X Link](https://x.com/GeneInvesting/status/2022527078344872213) [@GeneInvesting](/creator/x/GeneInvesting) 2026-02-14T04:23Z 15.3K followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
BridgeBio Pharma's stock surges to a 52-week and all-time high following positive Phase [--] results for BBP-418, driving significant market cap growth.
BridgeBio Pharma, Inc. Common Stock (BBIO) is a publicly traded stock in the healthcare sector focused on developing innovative medicines.
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week and all-time high, driven by highly positive Phase [--] results for BBP-418 and strong market performance, despite some concerns about European patent issues and company debt.
24-Hour: -1.06% 7-Day: 8.06% 30-Day: -1.32%
1-Year High: $79.90 on 2026-01-22
1-Year Low: $30.10 on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #253 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] [----]
[--] Months: [---] [---]
[--] Year: [---] +64
1-Year High: [-----] on 2026-01-26
1-Year Low: [--] on 2025-05-17
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +8
[--] Month: [--] [---]
[--] Months: [--] +10
[--] Year: [--] no change
1-Year High: [--] on 2025-12-08
1-Year Low: [--] on 2025-12-25
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +209%
[--] Month: [---------] +86%
[--] Months: [---------] -9.40%
[--] Year: [----------] +8.30%
1-Year High: [-------] on 2025-02-20
1-Year Low: [-----] on 2025-12-07
Engagements by network (24h): YouTube: [--] Reddit: [--] News: [--] TikTok: [--] X: [------]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +114%
[--] Month: [-----] +129%
[--] Months: [-----] +0.68%
[--] Year: [-----] +46%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): YouTube: [--] Reddit: [--] News: [--] TikTok: [--] X: [---]
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last [--] hours which is down 9.90% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +105%
[--] Month: [---] +144%
[--] Months: [-----] -12%
[--] Year: [-----] +91%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-12
The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @semodough | [--] | [------] | [--] | [-----] |
| @Andre_AGTC | [--] | [-----] | [--] | [-----] |
| @tallnfat | [--] | [------] | [--] | [---] |
| @thenewceo_ | [--] | [---] | [--] | [---] |
| @Pharmdca | [--] | [-------] | [--] | [---] |
| @Biotech2k1 | [--] | [------] | [--] | [---] |
| @BiotechAnalysst | [--] | [-----] | [--] | [---] |
| @biomednexus | [--] | [--] | [--] | [---] |
| @DwightS2025 | [--] | [---] | [--] | [---] |
| @GeneInvesting | [--] | [------] | [--] | [---] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 83%
Daily Average: 77%
[--] Week: 90% +5%
[--] Month: 79% +20%
[--] Months: 79% +2%
[--] Year: 79% +14%
1-Year High: 96% on 2025-10-06
1-Year Low: 40% on 2025-05-28
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.027%
Daily Average: 0.022%
[--] Week: 0.027% +0.019%
[--] Month: 0.054% +0.012%
[--] Months: 0.054% +0.024%
[--] Year: 0.054% +0.0089%
1-Year High: 0.068% on 2025-06-28
1-Year Low: 0.0058% on 2025-10-12
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.016%
Daily Average: 0%
1-Year High: 0.018% on 2026-01-02
1-Year Low: 0.00849% on 2025-05-28
Market Cap 24-Hour Time-Series Raw Data
Current Value: $14,419,930,847
Daily Average: $9,874,616,698
[--] Week: $14,419,930,847 +11%
[--] Month: $14,419,930,847 -1.30%
[--] Months: $14,419,930,847 +54%
[--] Year: $14,419,930,847 +117%
1-Year High: $15,312,912,611 on 2026-01-22
1-Year Low: $5,732,285,188 on 2025-04-08
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@BitcoinNewsCom Netherlands taxing unrealized gains is peak financial illiteracy. While you calculate paper losses $BBIO is printing 1.74-2.1 cm/year AHV gains and $SRPT durability is proven at [--] years. Move fast or stay poor"
X Link @thenewceo_ 2026-02-14T22:09Z [---] followers, [---] engagements
"$BBIO LR Model first year [----] all [--] drugs launched [---] Billion in revenue &EPS over [--] bucks $BBIO Bernstein updating $BBIO model PT $100 to reflect positive infigratinib data. there is much more of skeletal dysplasia story still to play out and the clean safety in particular gives us greater confidence in BBIO becoming the category leader. In terms of whats next $BBIO Bernstein updating $BBIO model PT $100 to reflect positive infigratinib data. there is much more of skeletal dysplasia story still to play out and the clean safety in particular gives us greater confidence in BBIO becoming the"
X Link @semodough 2026-02-14T22:04Z 42.5K followers, [----] engagements
"Buy Verified Bitget Accounts $VERO $ACCL $IBRX $LCFY $TNMG $BIYA $GWAV $ONDS $NVO $BBIO $T $MU $NVDA $QXO $UMC $INTC $SIDU $RZLV $NOK $BMNR $KRE $GDX $ITB $SLX $TAN $IYR $ROBO $INDA $IYZ $KWEB $BLOK $IDRV $FDN $SOXX $CLOU $BITO $ARKK https://seovcc.com/product/buy-verified-bitget-accounts/ https://seovcc.com/product/buy-verified-bitget-accounts/"
X Link @PandyAlina45893 2026-02-14T14:33Z [--] followers, [---] engagements
"@atticusanalysis @PersimmonTI Yeah $NTLA was actually performing way better than $BBIO before the obese [--] year old with [--] ulcer came"
X Link @GeneInvesting 2026-02-14T04:23Z 15.3K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$bbio